Natalia Elizalde, Ph.D., Business Development Director

San Sebastian, Spain


Virtual Presentation 

VIVEbiotech is a contract development and manufacturing organization developing and GMP manufacturing lentiviral vectors with wide and robust experience in manufacturing vectors for rare/ultra rare diseases and for immune-cell therapy projects. VIVEbiotech works according to the regulations of both the EMA and the FDA, and is manufacturing vectors for companies based in the U.S., Europe, and Asia. VIVEbiotech has an R&D department as well as two process optimization departments for both upstream production and downstream purification. The activities of these departments consist of improving the cost-effectiveness, scalability, regulatory, or quality compliance of the production process, and the intrinsic biological characteristics of the vectors themselves. VIVEbiotech has just opened new facilities for the manufacture of lentiviral vectors for the cell and gene therapy sector. The facility will be capable of manufacturing batches ranging from those for early-stage research to GMP for clinical and future commercial uses.

By using this website you agree to accept our Privacy Policy and Terms & Conditions